Cargando…
The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury
The e-cigarette or vaping product-use-associated lung injury (EVALI) epidemic was primarily associated with the use of e-cigarettes containing tetrahydrocannabinol (THC)- the principal psychoactive substance in cannabis, and vitamin-E-acetate- an additive sometimes used in informally sourced THC-con...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576092/ https://www.ncbi.nlm.nih.gov/pubmed/36251673 http://dx.doi.org/10.1371/journal.pone.0276187 |
_version_ | 1784811455731728384 |
---|---|
author | Boakye, Ellen El Shahawy, Omar Obisesan, Olufunmilayo Dzaye, Omar Osei, Albert D. Erhabor, John Uddin, S. M. Iftekhar Blaha, Michael J. |
author_facet | Boakye, Ellen El Shahawy, Omar Obisesan, Olufunmilayo Dzaye, Omar Osei, Albert D. Erhabor, John Uddin, S. M. Iftekhar Blaha, Michael J. |
author_sort | Boakye, Ellen |
collection | PubMed |
description | The e-cigarette or vaping product-use-associated lung injury (EVALI) epidemic was primarily associated with the use of e-cigarettes containing tetrahydrocannabinol (THC)- the principal psychoactive substance in cannabis, and vitamin-E-acetate- an additive sometimes used in informally sourced THC-containing e-liquids. EVALI case burden varied across states, but it is unclear whether this was associated with state-level cannabis vaping prevalence. We, therefore, used linear regression models to assess the cross-sectional association between state-level cannabis vaping prevalence (obtained from the 2019 behavioral Risk Factor Surveillance System) and EVALI case burden (obtained from the Centers for Disease Control and Prevention) adjusted for state cannabis policies. Cannabis vaping prevalence ranged from 1.14%(95%CI, 0.61%-2.12%) in Wyoming to 3.11%(95%CI, 2.16%-4.44%) in New Hampshire. EVALI cases per million population ranged from 1.90(0.38–3.42) in Oklahoma to 59.10(19.70–96.53) in North Dakota. There was no significant positive association but an inverse association between state cannabis vaping prevalence and EVALI case burden (Coefficient, -18.6; 95%CI, -37.5–0.4; p-value, 0.05). Thus, state-level cannabis vaping prevalence was not positively associated with EVALI prevalence, suggesting that there may not be a simple direct link between state cannabis vaping prevalence and EVALI cases, but rather the relationship is likely more nuanced and possibly reflective of access to informal sources of THC-containing e-cigarettes. |
format | Online Article Text |
id | pubmed-9576092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-95760922022-10-18 The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury Boakye, Ellen El Shahawy, Omar Obisesan, Olufunmilayo Dzaye, Omar Osei, Albert D. Erhabor, John Uddin, S. M. Iftekhar Blaha, Michael J. PLoS One Research Article The e-cigarette or vaping product-use-associated lung injury (EVALI) epidemic was primarily associated with the use of e-cigarettes containing tetrahydrocannabinol (THC)- the principal psychoactive substance in cannabis, and vitamin-E-acetate- an additive sometimes used in informally sourced THC-containing e-liquids. EVALI case burden varied across states, but it is unclear whether this was associated with state-level cannabis vaping prevalence. We, therefore, used linear regression models to assess the cross-sectional association between state-level cannabis vaping prevalence (obtained from the 2019 behavioral Risk Factor Surveillance System) and EVALI case burden (obtained from the Centers for Disease Control and Prevention) adjusted for state cannabis policies. Cannabis vaping prevalence ranged from 1.14%(95%CI, 0.61%-2.12%) in Wyoming to 3.11%(95%CI, 2.16%-4.44%) in New Hampshire. EVALI cases per million population ranged from 1.90(0.38–3.42) in Oklahoma to 59.10(19.70–96.53) in North Dakota. There was no significant positive association but an inverse association between state cannabis vaping prevalence and EVALI case burden (Coefficient, -18.6; 95%CI, -37.5–0.4; p-value, 0.05). Thus, state-level cannabis vaping prevalence was not positively associated with EVALI prevalence, suggesting that there may not be a simple direct link between state cannabis vaping prevalence and EVALI cases, but rather the relationship is likely more nuanced and possibly reflective of access to informal sources of THC-containing e-cigarettes. Public Library of Science 2022-10-17 /pmc/articles/PMC9576092/ /pubmed/36251673 http://dx.doi.org/10.1371/journal.pone.0276187 Text en © 2022 Boakye et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Boakye, Ellen El Shahawy, Omar Obisesan, Olufunmilayo Dzaye, Omar Osei, Albert D. Erhabor, John Uddin, S. M. Iftekhar Blaha, Michael J. The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury |
title | The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury |
title_full | The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury |
title_fullStr | The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury |
title_full_unstemmed | The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury |
title_short | The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury |
title_sort | inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576092/ https://www.ncbi.nlm.nih.gov/pubmed/36251673 http://dx.doi.org/10.1371/journal.pone.0276187 |
work_keys_str_mv | AT boakyeellen theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT elshahawyomar theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT obisesanolufunmilayo theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT dzayeomar theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT oseialbertd theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT erhaborjohn theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT uddinsmiftekhar theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT blahamichaelj theinverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT boakyeellen inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT elshahawyomar inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT obisesanolufunmilayo inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT dzayeomar inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT oseialbertd inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT erhaborjohn inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT uddinsmiftekhar inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury AT blahamichaelj inverseassociationofstatecannabisvapingprevalencewiththeecigaretteorvapingproductuseassociatedlunginjury |